1 |
[rituximab] |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
014 [1] 14 💬 |
2 |
Abatacept, rituximab or tocilizumab |
Abatacept |
[3] D02596 D02596, D02994 D02994, D03203 D03203 💬 |
CD80 [4] CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection [24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
3 |
Abp 798 - biosimilar to rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
4 |
Abp 798 biosimilar to rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
5 |
Administration of rituximab and methylprednisolone |
Methylprednisolone |
[7] D00407 D00407, D00751 D00751, D00979 D00979, D02994 D02994, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
6 |
Alemtuzumab and rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
060 [1] 60 💬 |
7 |
Alemtuzumab, rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
8 |
Arm b: rituxan®/mabthera® |
- |
- |
- |
- |
046 [1] 46 💬 |
9 |
Bendamustine, rituximab |
Bendamustine |
[3] D02994 D02994, D07085 D07085, D07501 D07501 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
061 [1] 61 💬 |
10 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
[12] D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
11 |
Combined plasma exchange (pex), rituximab, and corticosteroids |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |
12 |
Dexamethasone and rituximab |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
13 |
Double-blind rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
051 [1] 51 💬 |
14 |
Dr. reddy’s rituximab (drl_ri) 100mg |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
15 |
Dr. reddy’s rituximab (drl_ri) 500mg |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
16 |
Eltrombopag combining rituximab |
Eltrombopag |
[2] D02994 D02994, D03978 D03978 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
17 |
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab |
Abatacept |
[4] D02596 D02596, D02994 D02994, D03203 D03203, D10161 D10161 💬 |
CD80 [4] CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection [24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
18 |
Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
222 [1] 222 💬 |
19 |
Gp2013 - a proposed biosimilar rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
20 |
Idec-c2b8 (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
21 |
Immunosuppressive treatment (eg, rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
064 [1] 64 💬 |
22 |
Individualized dose of rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
23 |
Intravenous rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
066 [1] 66 💬 |
24 |
Mabthera (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [4] 13, 46, 49, 53 💬 |
25 |
Mabthera or biosimilar rituximab product |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
26 |
Mabthera/rituxan |
- |
- |
- |
- |
046 [1] 46 💬 |
27 |
Mabthera® (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
28 |
Originator rituximab - rituxan ® or mabthera ® |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
29 |
Prednisone, low dose rituximab |
Prednisone |
[2] D00473 D00473, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
30 |
Rhtpo in combination with rituximab |
Recombinant Human Thrombopoietin |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
31 |
Rituxan |
- |
- |
- |
- |
046 [4] 46, 60, 256, 288 💬 |
32 |
Rituxan (inn: rituximab), brand name in the united states |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
33 |
Rituxan (inn: rituximab), brand name in the us |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
34 |
Rituxan (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
35 |
Rituxan (us, canada, japan), mabthera (rest of the world) |
- |
- |
- |
- |
046 [1] 46 💬 |
36 |
Rituxan (us, canada, japan), mabthera (rest of world) |
- |
- |
- |
- |
053 [1] 53 💬 |
37 |
Rituxan® |
- |
- |
- |
- |
046 [1] 46 💬 |
38 |
Rituxan® (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
39 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
40 |
Rituximab (anti-cd20) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
053 [1] 53 💬 |
41 |
Rituximab (arm a) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
043 [2] 43, 44 💬 |
42 |
Rituximab (arm b) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
043 [2] 43, 44 💬 |
43 |
Rituximab (eu) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
44 |
Rituximab (genetical recombination) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
014 [1] 14 💬 |
45 |
Rituximab (mabthera® or rituxan®). |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
035 [2] 35, 61 💬 |
46 |
Rituximab (mabthera®) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
061 [1] 61 💬 |
47 |
Rituximab (rituxan) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [1] 11 💬 |
48 |
Rituximab (rtx) and azathioprine (aza) |
Azathioprine |
[3] D00238 D00238, D02994 D02994, D03033 D03033 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
065 [1] 65 💬 |
49 |
Rituximab (us) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
50 |
Rituximab - mabthera |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
51 |
Rituximab 1g iv |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
162 [1] 162 💬 |
52 |
Rituximab [mabthera/rituxan] |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [2] 46, 63 💬 |
53 |
Rituximab [mabthera] |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
54 |
Rituximab and cyclophosphamide iv |
Cyclophosphamide |
[3] D00287 D00287, D02994 D02994, D07760 D07760 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
035 [1] 35 💬 |
55 |
Rituximab combined with omalizumab |
Omalizumab |
[2] D02994 D02994, D05251 D05251 💬 |
FCER1A [2] FCER1A, MS4A1 💬 |
Asthma [5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
162 [1] 162 💬 |
56 |
Rituximab infusion |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [2] 13, 222 💬 |
57 |
Rituximab it |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
58 |
Rituximab iv |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
59 |
Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
60 |
Rituximab mabthera |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
61 |
Rituximab or rituximab hyaluronidase human |
Hyaluronidase |
[4] D02994 D02994, D04455 D04455, D04456 D04456, D06604 D06604 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
331 [1] 331 💬 |
62 |
Rituximab, mabthera |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
053 [1] 53 💬 |
63 |
Rituximab, mtx, folic acid |
Folic acid |
[2] D00070 D00070, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
64 |
Rituximab, observational study amon patients with active ra |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
65 |
Rituximab-eu+ rituximab-pfizer x 2 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
66 |
Rituximab-pfizer |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
67 |
Rituximab-pfizer (pf-05280586) x 3 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
68 |
Rituximab-us + rituximab-pfizer x 2 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
69 |
Rituximab/ mabthera |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
271 [1] 271 💬 |
70 |
Sait101 (proposed rituximab biosimilar) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
71 |
Sait101 (rituximab biosimilar) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
72 |
Standard dose of rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
73 |
The standard steroid treatment, plasma exchange and rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |